Image Cytometry Measures Mononuclear Cell Concentration
|
By LabMedica International staff writers Posted on 12 Feb 2013 |
A rapid fluorescence-based image cytometry system has been utilized for brightfield and fluorescence imaging analysis of cellular characteristics.
The viability and concentration of isolated peripheral blood mononuclear cells (PBMCs) are traditionally measured by manual counting with trypan blue (TB) using a hemacytometer, but red blood cell (RBC) contamination can be an issue.
Scientists at the Nexcelom Bioscience Laboratories, (Lawrence, MA, USA) compared their Cellometer Vision instrument with both manual counting and automatic method for accurately measuring the concentration of PBMCs in prepared blood samples. Fifteen freshly isolated samples were stained with acridine orange and propidium iodide (AO/PI) to identify RBC contamination. The five different methods were manual counting of TB-stained PBMCs in hemacytometer; manual counting of PBMCs in brightfield images; manual counting of acetic acid lysing of RBCs with TB-stained PBMCs; automated counting of acetic acid lysing of RBCs with PI-stained PBMCs; and AO/PI dual staining method.
Each of the 15 samples measured was categorized into low, medium, or high RBC contamination. Five samples showed less than 10% of RBC contamination, six samples showed 10% to 40% of RBC contamination, and four samples showed RBC contamination greater than 40%. The total particles counted in brightfield increased due to the addition of RBCs, while AO/PI staining showed consistent measurement of PBMCs, which again demonstrated the robustness of the method despite RBC contamination. Although inherent RBC contaminants may have existed in the sample, the purpose was to observe the increasing difference between fluorescently stained nucleated cells and total brightfield cell count including RBCs.
The authors concluded that fluorescence-based image cytometry can be utilized to eliminate the RBC-induced error in patient samples, which can improve accuracy and efficiency of PBMC measurement. Cellometer image cytometry has also demonstrated fluorescence-based cell population analysis such as apoptosis detection, cell cycle, as well as surface marker labeling. The system can be used to perform immunophenotyping of collected PBMCs, and can quickly characterize incoming patient samples, further simplifying PBMC characterization protocol. The study was published in the February 2013 issue of the Journal of Immunological Methods.
Related Links:
Nexcelom Bioscience
The viability and concentration of isolated peripheral blood mononuclear cells (PBMCs) are traditionally measured by manual counting with trypan blue (TB) using a hemacytometer, but red blood cell (RBC) contamination can be an issue.
Scientists at the Nexcelom Bioscience Laboratories, (Lawrence, MA, USA) compared their Cellometer Vision instrument with both manual counting and automatic method for accurately measuring the concentration of PBMCs in prepared blood samples. Fifteen freshly isolated samples were stained with acridine orange and propidium iodide (AO/PI) to identify RBC contamination. The five different methods were manual counting of TB-stained PBMCs in hemacytometer; manual counting of PBMCs in brightfield images; manual counting of acetic acid lysing of RBCs with TB-stained PBMCs; automated counting of acetic acid lysing of RBCs with PI-stained PBMCs; and AO/PI dual staining method.
Each of the 15 samples measured was categorized into low, medium, or high RBC contamination. Five samples showed less than 10% of RBC contamination, six samples showed 10% to 40% of RBC contamination, and four samples showed RBC contamination greater than 40%. The total particles counted in brightfield increased due to the addition of RBCs, while AO/PI staining showed consistent measurement of PBMCs, which again demonstrated the robustness of the method despite RBC contamination. Although inherent RBC contaminants may have existed in the sample, the purpose was to observe the increasing difference between fluorescently stained nucleated cells and total brightfield cell count including RBCs.
The authors concluded that fluorescence-based image cytometry can be utilized to eliminate the RBC-induced error in patient samples, which can improve accuracy and efficiency of PBMC measurement. Cellometer image cytometry has also demonstrated fluorescence-based cell population analysis such as apoptosis detection, cell cycle, as well as surface marker labeling. The system can be used to perform immunophenotyping of collected PBMCs, and can quickly characterize incoming patient samples, further simplifying PBMC characterization protocol. The study was published in the February 2013 issue of the Journal of Immunological Methods.
Related Links:
Nexcelom Bioscience
Latest Immunology News
- Aptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
- Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
- Study Points to Autoimmune Pathway Behind Long COVID Symptoms
- Immune Enzyme Linked to Treatment-Resistant Inflammatory Bowel Disease
- Simple Blood Test Could Replace Biopsies for Lung Transplant Rejection Monitoring
- Routine TB Screening Test May Reveal Immune Aging and Mortality Risk
- Biomarkers and Molecular Testing Advance Precision Allergy Care
- Point-of-Care Tests Could Expand Access to Mpox Diagnosis
- T-Cell Senescence Profiling May Predict CAR T Responses
- Finger-Prick Lateral Flow Test Detects Sepsis Biomarkers at Point of Care
- Study Highlights Low Sensitivity of Current Lyme Tests in Early Infection
- Immune Aging Clock Quantifies Immunosenescence and Identifies Therapeutic Target
- Study Finds Influenza Often Undiagnosed in Winter Deaths
- Combined Screening Approach Identifies Early Leprosy Cases
- Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection
- FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas
Channels
Clinical Chemistry
view channel
Saliva-Based Test Detects Biochemical Signs of Sleep Loss
Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. Clinicians currently lack an objective biochemical test to determine when someone is dangerously... Read more
Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more
Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
Blood-based screening for Alzheimer’s disease offers a noninvasive, lower-cost alternative to brain imaging or spinal fluid testing, yet its ability to flag the earliest cognitive changes has been unclear.... Read moreMolecular Diagnostics
view channel
New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance
Rapid identification of Ebola infections is essential to limit transmission and guide public health response, yet detection can be difficult when outbreaks involve rare variants. The current outbreaks... Read more
Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead
Lung cancer remains a leading cause of cancer death, and many cases are detected only after symptoms appear. Current screening programs largely target people with a history of smoking, leaving other at-risk... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreMicrobiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read morePathology
view channel
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more








